New Jersey expands pharmacist authority for at-home COVID-19 and flu test kit distribution

Deborah Hartel, Deputy Commissioner, Integrated Health at New Jersey Department of Health
Deborah Hartel, Deputy Commissioner, Integrated Health at New Jersey Department of Health
0Comments

The New Jersey Department of Health (NJDOH) has issued a new permanent order allowing pharmacists in the state to dispense FDA-authorized at-home COVID-19 and flu test kits without a prescription. This measure is intended to make it easier for residents to access testing during a winter marked by high flu activity.

Officials say that early detection through testing is key to preventing severe complications and further transmission, especially among vulnerable groups such as children and people with underlying health conditions. Acting Commissioner Raynard E. Washington stated, “During this season of low temperatures and high flu activity, we must use all available tools to prevent the spread of respiratory viruses. At-home tests can speed up diagnosis, helping to prevent further spread and allowing the opportunity for treatment. We are removing potential barriers so residents can make informed decisions about their health and well-being.”

The new order enables eligible individuals with medical coverage in New Jersey to obtain home test kits without a prescription. It may also allow Medicaid and other insurers to cover the cost of these kits, reducing out-of-pocket expenses for patients.

This policy builds on existing NJDOH efforts to improve access to home testing for both flu and COVID-19. Through its Division of Disaster Preparedness, Resilience, and Emergency Medical Services, the department distributes over-the-counter test kits to county and local health departments serving vulnerable populations. Over 72,000 test kits have been distributed across New Jersey this season.

Novneet Sahu, MD, Deputy Commissioner of Public Health Services who signed the regulation, said, “The window for starting treatment against flu or COVID-19 is narrow—often just days after symptoms begin. At-home tests help people find out sooner, giving them a chance for treatment and helping reduce cases of severe illness, hospitalization, or even death. If your healthcare provider recommends you take an at-home flu or COVID-19 test, this permanent order can make it easier to get one.”

Health officials note that not all patients need a flu test before beginning antiviral treatment; clinicians often diagnose based on symptoms alone during peak flu activity.

Vaccination remains the most effective way to prevent influenza and its complications. The department urges everyone—especially those at higher risk such as young children, pregnant or recently postpartum individuals, and people with chronic illnesses—to stay current with their vaccines. Those at high risk for COVID-19 include people over 60 years old and those with preexisting conditions like compromised immune systems or chronic lung or heart diseases.

Good hygiene practices—including covering coughs and sneezes, frequent handwashing, and cleaning high-touch surfaces—also help prevent illness. Anyone who contracts a virus should remain at home.

Residents are encouraged to discuss vaccines, testing options, and treatments with their healthcare providers in order to help prevent disease spread.

Further information about respiratory viruses can be found on the New Jersey Department of Health website: https://nj.gov/health/respiratory-viruses



Leave a Reply

Your email address will not be published. Required fields are marked *

Related

Chris Emigholz Chief Government Affairs Officer

Chris Emigholz discusses state budget proposal on NJCPA IssuesWatch podcast

Chris Emigholz from NJBIA appeared on the IssuesWatch podcast discussing concerns over an employer Medicaid tax proposal in Governor Sherrill’s new budget plan. He outlined how penalties could affect businesses even when they offer employee healthcare options. The conversation highlights ongoing debates about policies impacting New Jersey employers.

Michele Siekerka President & CEO

Soaring gasoline prices drive inflation higher in March

Inflation climbed sharply in March due mainly to rising gasoline prices linked to conflict abroad. Federal data show broad increases across several sectors even as some categories declined.

Michele Siekerka President & CEO

EPA delays PFAS reporting rule submission date for businesses to 2027

The Environmental Protection Agency has postponed key PFAS product reporting requirements until at least January 31, 2027. Businesses now have additional time before compliance deadlines take effect under revised federal rules.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from North Jersey Business Daily.